Dr. Eric Tyrell Oliver, MD

Dr. Oliver practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Oliver's NPI, 1912168113, was assigned on June 19, 2008. Dr. Oliver graduated from University of South Carolina School of Medicine in 2008. Dr. Oliver holds Maryland license D77745.

Dr. Oliver's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Oliver's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Oliver is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Oliver to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oliver practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Oliver's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dr. Oliver is licensed in Maryland.

CMS data shows 17 Medicare services from Dr. Oliver across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $1,224 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Oliver in 2024. The largest group is under 65, with 11 patients. 69% of them have high cholesterol, and 65% have high blood pressure. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oliver's median patient age at 64, with 75% women.

In 2024, Dr. Oliver wrote 30 Medicare Part D claims. 37% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $717 in total drug cost. In 2021, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Oliver for performance year 2024, reported as part of a group.

Dmand AI links 15 papers to Dr. Oliver, published from 2015 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Urticaria, Basophils and Chronic Urticaria. Dr. Oliver has published most often in J Allergy Clin Immunol Pract. Dr. Oliver's most frequent co-authors are Sarbjit Saini, MD, Jonathan Bernstein, MD and Jonathan A. Bernstein, MD.

Dmand AI links Dr. Oliver to 2 clinical trials. Conditions studied include Chronic Urticaria, Rhinitis, Allergic and Rhinitis. Open Payments lists research payments to Dr. Oliver that name 1 trial.

CMS Open Payments shows 82 general payments to Dr. Oliver from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Novartis Pharmaceuticals Corporation paid the most, $11,576. It also lists 11 research payments totaling $1,370 in 2018, naming 1 clinical trial.

Dr. Oliver graduated from University of South Carolina School of Medicine in 2008.